Post-rituximab Burkitt transformation of PTLD: Loss of CD20 expression accompanied by a switch in light-chain expression

Annals of Hematology

Volumn 89, Issue 1, 2010, Pages 97-99

  Hwang, Yu Yan ^a   Wong, Kai Y ^a   Leung, Rock Y Y ^a   Wong, Simon H M ^a   Chan, See Ching ^a   Srivastava, Gopesh ^a   Au, Wing Y ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CD79 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; EPIRUBICIN; EPSTEIN BARR VIRUS RNA; IMMUNOGLOBULIN KAPPA CHAIN; LACTATE DEHYDROGENASE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; TACROLIMUS; UNCLASSIFIED DRUG; URIC ACID; VINCRISTINE; VIRUS RNA;

AGED; BONE MARROW BIOPSY; BURKITT LYMPHOMA; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; FEMALE; FEVER; GENE EXPRESSION; HEPATOSPLENOMEGALY; HUMAN; IMMUNOELECTROPHORESIS; KIDNEY DISEASE; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LIGHT CHAIN; LIVER GRAFT REJECTION; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; POST TRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; REMISSION; TREATMENT RESPONSE; URIC ACID BLOOD LEVEL;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; BASE SEQUENCE; BURKITT LYMPHOMA; CELL TRANSFORMATION, NEOPLASTIC; FATAL OUTCOME; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; MOLECULAR SEQUENCE DATA;

EID: 71349084620     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0769-8     Document Type: Letter

References (7)

1. G Touchard T Pasdeloup J Parpeix T Hauet M Bauwens G Dumont, et al. 1997 High prevalence and usual persistence of serum monoclonal immunoglobulins evidenced by sensitive methods in renal transplant recipients Nephrol Dial Transplant 12 6 1199 1203 10.1093/ndt/12.6.1199 1:STN:280:DyaK2szktFyhuw%3D%3D 9198051 (Pubitemid 27230557)
2. WY Au G Srivastava KY Wong LP Chung SK Ma TS Wan, et al. 2004 Transformation of diffuse large B-cell lymphoma into pre-B acute lymphoblastic leukemia: clinicopathologic features and clonal relationship Hum Pathol 35 7 900 903 10.1016/j.humpath.2004.04.002 1:STN:280:DC%2BD2czltlCmtg%3D%3D 15257558 (Pubitemid 38903088)
3. WY Au K Wong JC So TS Wan G Svrivastava R Liang, et al. 2009 A unique case of B cell lymphoma relapsing as CD4/CD56 blastic neoplasm Leuk Lymphoma 50 6 932 936 10.1080/10428190902878463 1:CAS:528:DC%2BD1MXntFChtr4%3D 19504395
4. JM Timms A Bell JR Flavell PG Murray AB Rickinson A Traverse-Glehen, et al. 2003 Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma Lancet 361 9353 217 223 10.1016/S0140-6736(03)12271-4 12547545 (Pubitemid 36126222)
5. SH Oertel E Verschuuren P Reinke K Zeidler M Papp-Vary N Babel, et al. 2005 Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD) Am J Transplant 5 12 2901 2906 10.1111/j.1600-6143.2005.01098.x 1:CAS:528:DC%2BD2MXhtlGns7zL 16303003 (Pubitemid 43923950)
6. PG Chu YY Chen A Molina DA Arber LM Weiss 2002 Recurrent B-cell neoplasms after rituximab therapy: an immunophenotypic and genotypic study Leuk Lymphoma 43 12 2335 2341 10.1080/1042819021000040044 1:CAS:528:DC%2BD3sXhtlyjtw%3D%3D 12613521
7. T Alvaro-Naranjo J Jaen-Martinez J Guma-Padro R Bosch-Princep MT Salvado-Usach 2003 CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature Ann Hematol 82 9 585 588 10.1007/s00277-003-0694-1 1:STN:280:DC%2BD3svktlGruw%3D%3D 12898184 (Pubitemid 37220678)